Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Fabhalta Global Growth in Constant Currencies by Quarter
Fabhalta Global Growth in Constant Currencies (% cc) (%)
Novartis Fabhalta Global Growth in Constant Currencies: 60.0% in Q3 2026, down 176.0 pts from a year earlier.
Latest, Q3 2026
60.0%
Period ended Sep 30, 2026
Change on a year earlier
-176.0 pts
236.0% in Q3 2025
History
5 quarters
Since Q3 2025
Sources
5
Documents cited below
Where the Q3 2026 figure comes from
“|| Fabhalta 3 | 237 | 149 | 59 | 60”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Form 6-K & Form 20-F.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Fabhalta Global Growth in Constant Currencies (% cc) (%) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 60.0% | -176.0 pts | Novartis Form 6-K (0001114448-26-000014) ↗ |
| Q2 2026 | Jun 30, 2026 | 88.0% | – | Novartis Form 6-K (0001114448-26-000012) ↗ |
| Q1 2026 | Mar 31, 2026 | 103.0% | – | Novartis Form 6-K (0001114448-26-000010) ↗ |
| Q4 2025 | Dec 31, 2025 | 167.0% | – | Novartis Form 6-K (0001114448-26-000007) ↗ |
| Q3 2025 | Sep 30, 2025 | 236.0% | – | Novartis Form 6-K (0001114448-25-000003) ↗ |
Cite this data
StockData. (2026). Novartis Fabhalta Global Growth in Constant Currencies (%), quarterly Q3 2025–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-fabhalta-yoy-cc-pct
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.